Purple Biotech Future Growth
Future criteria checks 0/6
Purple Biotech is forecast to grow revenue at 100.3% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 16.6% |
Revenue growth rate | 100.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 19 Sep 2024 |
Recent future growth updates
No updates
Recent updates
We're A Little Worried About Purple Biotech's (TLV:PPBT) Cash Burn Rate
Mar 07Can Purple Biotech (TLV:PPBT) Afford To Invest In Growth?
Oct 30Will Purple Biotech (TLV:PPBT) Spend Its Cash Wisely?
Jul 17Here's Why We're Watching Purple Biotech's (TLV:PPBT) Cash Burn Situation
Mar 13Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?
Nov 27Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?
Jul 21Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans
Mar 25Companies Like Purple Biotech (TLV:PPBT) Are In A Position To Invest In Growth
Dec 09Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans
May 28We Think Purple Biotech (TLV:PPBT) Can Afford To Drive Business Growth
Feb 11If You Had Bought Purple Biotech's (TLV:KTOV) Shares Five Years Ago You Would Be Down 90%
Dec 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | N/A | -15 | N/A | 1 |
12/31/2025 | N/A | N/A | -7 | N/A | 1 |
12/31/2024 | N/A | N/A | -2 | N/A | 1 |
9/30/2024 | N/A | -12 | -17 | -17 | N/A |
6/30/2024 | N/A | -16 | -18 | -18 | N/A |
3/31/2024 | N/A | -19 | -19 | -19 | N/A |
12/31/2023 | N/A | -20 | -20 | -20 | N/A |
9/30/2023 | N/A | -21 | -19 | -19 | N/A |
6/30/2023 | N/A | -21 | -19 | -19 | N/A |
3/31/2023 | N/A | -19 | -18 | -18 | N/A |
12/31/2022 | N/A | -22 | -17 | -17 | N/A |
9/30/2022 | N/A | -20 | -17 | -16 | N/A |
6/30/2022 | N/A | -19 | -16 | -16 | N/A |
3/31/2022 | N/A | -19 | -17 | -17 | N/A |
12/31/2021 | N/A | -18 | -15 | -15 | N/A |
9/30/2021 | N/A | -13 | N/A | N/A | N/A |
6/30/2021 | -1 | -11 | -16 | -16 | N/A |
3/31/2021 | 1 | -21 | N/A | N/A | N/A |
12/31/2020 | N/A | -29 | -12 | -12 | N/A |
9/30/2020 | 1 | -30 | -10 | -10 | N/A |
6/30/2020 | 1 | -31 | -8 | -8 | N/A |
3/31/2020 | 1 | -18 | -7 | -7 | N/A |
12/31/2019 | N/A | -5 | -6 | -6 | N/A |
9/30/2019 | 1 | -4 | -6 | -6 | N/A |
6/30/2019 | 1 | -3 | -7 | -7 | N/A |
3/31/2019 | 1 | -4 | -8 | -8 | N/A |
12/31/2018 | 1 | -5 | -8 | -8 | N/A |
9/30/2018 | 1 | -8 | -8 | -8 | N/A |
6/30/2018 | 1 | -11 | N/A | -7 | N/A |
3/31/2018 | 1 | -12 | N/A | -8 | N/A |
12/31/2017 | 0 | -12 | N/A | -9 | N/A |
9/30/2017 | 0 | -14 | N/A | -9 | N/A |
6/30/2017 | N/A | -15 | N/A | -9 | N/A |
3/31/2017 | N/A | -14 | N/A | -7 | N/A |
12/31/2016 | N/A | -12 | N/A | -6 | N/A |
9/30/2016 | N/A | -9 | N/A | -5 | N/A |
6/30/2016 | N/A | -6 | N/A | -4 | N/A |
3/31/2016 | N/A | -5 | N/A | -4 | N/A |
12/31/2015 | N/A | -4 | N/A | -3 | N/A |
9/30/2015 | N/A | -4 | N/A | -3 | N/A |
6/30/2015 | N/A | -4 | N/A | -3 | N/A |
3/31/2015 | N/A | -5 | N/A | -3 | N/A |
12/31/2014 | N/A | -5 | N/A | -5 | N/A |
9/30/2014 | N/A | -5 | N/A | -4 | N/A |
6/30/2014 | N/A | -6 | N/A | -3 | N/A |
3/31/2014 | N/A | -4 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PPBT's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if PPBT's earnings are forecast to grow faster than the IL market
High Growth Earnings: Insufficient data to determine if PPBT's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PPBT is forecast to have no revenue next year.
High Growth Revenue: PPBT is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PPBT's Return on Equity is forecast to be high in 3 years time